Compare VOR & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VOR | SWIM |
|---|---|---|
| Founded | 2015 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 963.2M |
| IPO Year | 2021 | 2021 |
| Metric | VOR | SWIM |
|---|---|---|
| Price | $19.85 | $7.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | ★ $39.00 | $8.80 |
| AVG Volume (30 Days) | 794.6K | ★ 1.1M |
| Earning Date | 10-30-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 160.00 |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $545,912,000.00 |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | N/A | $5.91 |
| P/E Ratio | ★ N/A | $58.43 |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $6.50 | $4.64 |
| 52 Week High | $26.00 | $8.97 |
| Indicator | VOR | SWIM |
|---|---|---|
| Relative Strength Index (RSI) | 51.11 | 70.11 |
| Support Level | $17.44 | $5.91 |
| Resistance Level | $20.11 | $7.87 |
| Average True Range (ATR) | 1.24 | 0.31 |
| MACD | 0.12 | 0.15 |
| Stochastic Oscillator | 50.99 | 80.19 |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. The company derives a majority of its revenue from the United States.